Birzeit Pharmaceuticals Company

PLSE:BPC Stock Report

Market Cap: US$144.6m

Birzeit Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Talal Kadhim Nasereddin

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure34.8yrs
CEO ownership16.8%
Management average tenureno data
Board average tenure21.2yrs

Recent management updates

Recent updates


CEO

Talal Kadhim Nasereddin (75 yo)

34.8yrs

Tenure

US$35,460

Compensation

Mr. Talal Kadhim Abdellah Nasereddin has been the Chairman of the Board at Birzeit Pharmaceuticals Company since 1990 and also served as it's General Manager since January 4, 1984 until October 31, 2024 an...


Board Members

NamePositionTenureCompensationOwnership
Talal Kadhim Nasereddin
Chairman of the Board34.8yrsUS$35.46k16.78%
$ 24.3m
Firas Kathem Nasereddin
Director of Marketing Dept.21.2yrsUS$35.46k6.48%
$ 9.4m
Azzam Shawwa
Directorno datano datano data
Farhan Naser Abu Lail Lail
Director34.3yrsUS$35.46kno data
Salem Mostafa Salem Khaizaran
Director13.6yrsUS$35.46kno data
Yahya Mohammad Shawar
Director32.5yrsUS$35.46kno data
Mohammad Hussein Nasereddin
Director1.5yrsno datano data
Rasha Nasereddin
Director1.9yrsno datano data

21.2yrs

Average Tenure

61yo

Average Age

Experienced Board: BPC's board of directors are seasoned and experienced ( 21.2 years average tenure).